Regulatory & Compliance

Will New FDA Guidance Expand Access to Cancer Trials?
Research & Development Will New FDA Guidance Expand Access to Cancer Trials?

The profound disconnect between the high percentage of cancer patients willing to participate in clinical research and the small fraction who actually enroll has long been an industry bottleneck. While data consistently shows that more than seventy percent of individuals battling cancer express a

Is Your Health Data Safe After the CareCloud AWS Breach?
Tech & Innovation Is Your Health Data Safe After the CareCloud AWS Breach?

The intersection of cloud computing and medical infrastructure has created a paradox where the convenience of instant access to patient records often clashes with the fundamental necessity of rigorous data security protocols. When a major healthcare technology provider like CareCloud experiences a

Weill Cornell Medicine Settles $1 Billion Sexual Abuse Case
Management & Regulatory Weill Cornell Medicine Settles $1 Billion Sexual Abuse Case

The recent announcement that Weill Cornell Medicine has agreed to pay over one billion dollars to resolve claims of widespread sexual abuse marks a seismic shift in medical industry accountability. This historic settlement, which addresses the horrific actions of former urologist Dr. Darius Paduch,

Partnered Health Data Breach Impacts $450 Million Bupa Deal
Management & Regulatory Partnered Health Data Breach Impacts $450 Million Bupa Deal

The recent discovery of a sophisticated cybersecurity breach at Partnered Health has sent shockwaves through the Australian healthcare landscape, occurring at the most precarious moment for the medical provider and its prospective buyer. On June 23, 2026, the organization identified a significant

How Does Medicare Support Your Virtual Doctor Visits?
Management & Regulatory How Does Medicare Support Your Virtual Doctor Visits?

The rapid transformation of healthcare delivery has fundamentally altered how millions of beneficiaries access essential medical services without leaving their homes. This evolution reflects a broader recognition that physical distance should not be a barrier to high-quality clinical outcomes or

New Models Scale Personalized Rare Disease Therapies
Research & Development New Models Scale Personalized Rare Disease Therapies

The pharmaceutical landscape is undergoing a radical transformation as the era of blockbuster drugs for the masses gives way to a highly specialized approach designed for individuals with unique genetic mutations. This paradigm shift was catalyzed by the landmark case of Mila Makovec, who faced a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later